Insight Molecular Diagnostics Inc.
corporate_fare Company Profile
Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 25 items for IMDX at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Activist Investor Broadwood Partners Increases Stake to 37.4% with $3M Premium Purchase
- 10% Owner Broadwood Partners Buys $3M in Recent Registered Direct Offering at Premium
- Insight Molecular Diagnostics Finalizes $26M Registered Direct Offering at Premium
- Insight Molecular Diagnostics Finalizes $26M Offering at Deep Discount to Prior Close
- Insight Molecular Diagnostics Details Progress on GraftAssureDx, Upcoming FDA Submission, and Strategic Partnership
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$4.05M
Net Income
-$50.22M
Diluted EPS
-$1.65
Op. Cash Flow
-$22.18M
Free Cash Flow
-$25.37M
Gross Profit
$2.3M
Operating Income
-$51.12M
Cash & Equivalents
$11.58M
Debt / Equity
0.00×
Net Margin
-12.39×
Shares Outstanding
28.68M sh
Source: 10-K · filed 2026-03-26 · accession 0001642380-26-000004
show_chartPrice Chart
Loading chart...
feed IMDX - Filings & News (Page 2)
IMDX
Feb 12, 2026, 7:52 PM EST
Price at Filing:
$5.58
Real-time Price:
$1.94
Change:
-$3.64 (-65%)
Market Cap:
$64.532M
IMDX
Feb 12, 2026, 7:49 PM EST
Price at Filing:
$5.58
Real-time Price:
$1.94
Change:
-$3.64 (-65%)
Market Cap:
$64.532M
IMDX
Feb 12, 2026, 5:20 PM EST
Price at Filing:
$5.58
Real-time Price:
$1.94
Change:
-$3.64 (-65%)
Market Cap:
$64.532M
IMDX
Feb 11, 2026, 4:55 PM EST
Price at Filing:
$5.73
Real-time Price:
$1.94
Change:
-$3.79 (-66%)
Market Cap:
$64.532M
IMDX
Feb 11, 2026, 8:05 AM EST
Price at Filing:
$6.25
Real-time Price:
$1.94
Change:
-$4.31 (-69%)
Market Cap:
$64.532M